Drug Shortage Report for TELMISARTAN
| Report ID | 211177 |
| Drug Identification Number | 02390345 |
| Brand name | TELMISARTAN |
| Common or Proper name | Telmisartan |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-28 |
| Estimated end date | 2024-04-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-11-22 | French | Compare |
| v1 | 2023-11-22 | English | Compare |
Showing 1 to 2 of 2